IP Library Granted Patent US 8,303,477
Granted Patent B2
US 8,303,477 · App. 11/895,559 · Granted Nov 6, 2012

Fluid radiation shield for brachytherapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,303,477
App. No.
11/895,559
Granted
Nov 6, 2012
Kind
B2
Abstract

A brachytherapy treatment device includes an insertion member, an expandable chamber, and first and second immiscible fluids. The insertion member has proximal and distal ends. The expandable chamber is disposed on the distal end of the insertion member and has an inner surface defining a three-dimensional volume. First and second immiscible fluids are disposed within the expandable chamber and have different radiation absorption properties. At least one of the first and second immiscible fluids forms a fluid radiation shield having a predetermined orientation within the three-dimensional volume. First and second immiscible fluids may have different densities and utilize fluid buoyancy to form an symmetric fluid radiation shield to create an asymmetric radiation dosing profile relative to an inner boundary of a treatment site. Methods for performing brachytherapy treatment include positioning fluids and/or a patient to form an asymmetric fluid radiation shield in a desired orientation to protect sensitive tissues.

Claims (26)

1. A brachytherapy treatment device, comprising:

a tubular insertion member having a proximal end and a distal end;

an expandable chamber disposed on the distal end of the tubular insertion member and having an inner surface defining a three-dimensional volume; and

first and second immiscible fluids disposed within the expandable chamber and having different radiation absorption properties, wherein at least one of the first and second immiscible fluids forms a fluid radiation shield having a predetermined orientation within the three-dimensional volume.

2. The device of claim 1 , wherein the first and second immiscible fluids have different densities and utilize fluid buoyancy to form a fluid radiation shield having a predetermined orientation.

3. The device of claim 1 , wherein the first and second immiscible fluids form an asymmetric fluid radiation shield to create an asymmetric radiation dosing profile relative to an inner boundary of target tissue.

4. The device of claim 1 , wherein the predetermined orientation of the fluid radiation shield is determined by direction of gravity.

5. The device of claim 1 , wherein the predetermined orientation of the fluid radiation shield is determined by application of an external stimuli.

6. The device of claim 1 , wherein the at least one of the first and second immiscible fluids disposed within the expandable chamber forms a solid radiation shield having a predetermined orientation.

7. The device of claim 1 , further comprising a second expandable chamber disposed on the distal end of the tubular insertion member, the second expandable chamber surrounding the expandable chamber.

8. The device of claim 1 , further comprising a radiation source position located within the expandable chamber, wherein the and second immiscible fluids substantially surround the radiation source position.

9. A method for performing brachytherapy treatment, comprising:

placing a catheter within a patient at a treatment site, wherein the catheter has a proximal end and a distal end having an expandable chamber disposed thereon, the expandable chamber inflatable via the proximal end to substantially fill an inner boundary of the treatment site;

injecting at least first and second immiscible fluids into the expandable chamber, wherein the first and second immiscible fluids have different radiation absorption properties; and

placing a radiation source at the treatment site.

10. The method of claim 9 , wherein orientation of the first and second immiscible fluids relative to the radiation source forms a predetermined fluid radiation shield.

11. The method of claim 9 , wherein the first and second immiscible fluids have different densities and utilize fluid buoyancy to create an asymmetric fluid radiation shield.

12. The method of claim 9 , wherein the first and second immiscible fluids form a predetermined fluid radiation shield to create an asymmetric radiation dosing profile relative to an inner boundary of the treatment site.

13. The method of claim 9 , further comprising positioning the patient to allow a stimuli to orient at least one of the first and second immiscible fluids within the expandable chamber.

14. The method of claim 9 , further comprising applying a stimuli to change a physical state of at least one of the first and second immiscible fluids.

15. The method claim 9 , wherein the predetermined orientation of the fluid radiation shield is determined by direction of gravity.

16. The method claim 9 , wherein the predetermined orientation of the fluid radiation shield is determined by external stimuli.

17. The method of claim 9 , further comprising the steps of:

injecting the first immiscible fluid into the expandable chamber;

applying a stimuli to cause the first immiscible fluid in the expandable chamber to change physical state; and

injecting the second immiscible fluid into the expandable chamber.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0879 →
PATENT SECURITY AGREEMENT Recorded Oct 26, 2007
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P.
Reel/Frame 020018/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2007
From: MARTIN, GREGORY T.
To: CYTYC CORPORATION
Reel/Frame 019800/0169 →